4.7 Article

Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles

Journal

FERTILITY AND STERILITY
Volume 90, Issue 6, Pages 2281-2286

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2007.10.057

Keywords

Clomiphene citrate; intrauterine insemination; infertility; assisted reproductive technology; artificial insemination; ART outcomes

Funding

  1. Speakers Bureau
  2. EMD Serono and Organon, Inc.

Ask authors/readers for more resources

Objective: To evaluate the outcomes of a large cohort of patients undergoing fertility treatment with clomiphene citrate and intrauterine insemination. Design: A retrospective cohort study. Setting: Boston IVF, a large university-affiliated reproductive medicine practice. Patient(s): A total of 4,199 cycles performed in 1,738 infertility patients between September 2002 and July 2007. Intervention(S): All patients received oral clomiphene citrate, and patients with completed cycles had intrauterine insemination performed. Main Outcome Measure(s): Cumulative and per cycle pregnancy rates achieved among subsets of patients defined by age, completed cycles, and intention to treat (ITT). Result(s): For women under age 35 years, 2,351 cycles were initiated in 983 patients. A total of 238 pregnancies ensued, yielding a pregnancy rate (PR) per completed cycle of 11.5% and 10.1% per cycle initiated with ITT. In women aged 35-37 years, 947 cycles in 422 women lead to a PR per completed cycle and ITT of 9.2% and 8.2%, respectively. For patients aged 38-40 years, 614 cycles in 265 women lead to a PR per completed cycle and ITT of 7.3% and 6.5%, respectively. In women aged 41-42 years, 166 cycles in 81 patients lead to a PR per completed cycle and ITT of 4.3% and 3.6%, respectively. For women above age 42 years, 120 cycles in 55 patients lead to a PR per completed cycle and ITT of 1.0% and 0.8%, respectively. On a per-patient treated basis, cumulative PRs were 24.2% under age 35, 18.5% ages 35-37, and 15.1% ages 38-40, whereas only 7.4% ages 41-42 and 1.8% above 42 became pregnant (one pregnancy in 55 patients). Conclusion(s): As anticipated, younger patients have a higher PR per cycle than older patients. The PR per cycle for patients who initiate only one or only two treatment cycles is notably higher than the corresponding per cycle rates for cycles 3 through 9. The drop in success per patient among 41- and 42-year-olds is sharp, but the exceptionally low success rate above age 42 suggests that CC with IUI has virtually no place in their treatment:. (Fertil Steril (R) 2008;90:2281-6. (C) 2008 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Obstetrics & Gynecology

Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices

Thomas L. Toth, Malinda S. Lee, Kristin A. Bendikson, Richard H. Reindollar

FERTILITY AND STERILITY (2017)

Article Obstetrics & Gynecology

Optimizing natural fertility: a committee opinion

FERTILITY AND STERILITY (2017)

Article Obstetrics & Gynecology

How many oocytes are optimal to achieve multiple live births with one stimulation cycle? The one-and-done approach

Denis A. Vaughan, Angela Leung, Nina Resetkova, Robin Ruthazer, Alan S. Penzias, Denny Sakkas, Michael M. Alper

FERTILITY AND STERILITY (2017)

Article Obstetrics & Gynecology

ASRM standard embryo transfer protocol template: a committee opinion

Alan Penzias, Kristin Bendikson, Samantha Butts, Christos Coutifaris, Tommaso Falcone, Gregory Fossum, Susan Gitlin, Clarisa Gracia, Karl Hansen, Jennifer Mersereau, Randall Odem, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Michael Vernon

FERTILITY AND STERILITY (2017)

Article Obstetrics & Gynecology

Thicker endometrial linings are associated with better IVF outcomes: a cohort of 6331 women

Emily C. Holden, Laura E. Dodge, Rita Sneeringer, Vasiliki A. Moragianni, Alan S. Penzias, Michele R. Hacker

HUMAN FERTILITY (2018)

Article Obstetrics & Gynecology

Evaluation of the azoospermic male: a committee opinion

Kathleen Hwang, James F. Smith, R. Matthew Coward, Alan Penzias

FERTILITY AND STERILITY (2018)

Article Obstetrics & Gynecology

The role of immunotherapy in in vitro fertilization: a guideline

Alan Penzias, Kristin Bendikson, Samantha Butts, Christos Coutifaris, Tommaso Falcone, Susan Gitlin, Clarisa Gracia, Karl Hansen, Sangita Jindal, Jennifer Mersereau, Randall Odem, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Peter Schlegel, Dale Stovall, Michael Vernon

FERTILITY AND STERILITY (2018)

Article Obstetrics & Gynecology

Smoking and infertility: a committee opinion

Alan Penzias, Kristin Bendikson, Samantha Butts, Christos Coutifaris, Tommaso Falcone, Susan Gitlin, Clarisa Gracia, Karl Hansen, Sangita Jindal, Suleena Kalra, Jennifer Mersereau, Randall Odem, Richard Paulson, Samantha Pfeifer, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Peter Schlegel, Dale Stovall, Michael Vernon

FERTILITY AND STERILITY (2018)

Article Obstetrics & Gynecology

IVF success corrected for drop-out: use of inverse probability weighting

Anna M. Modest, Lauren A. Wise, Matthew P. Fox, Jennifer Weuve, Alan S. Penzias, Michele R. Hacker

HUMAN REPRODUCTION (2018)

Article Genetics & Heredity

Hippo signaling in the ovary and polycystic ovarian syndrome

Kristi Maas, Sheyla Mirabal, Alan Penzias, Paul M. Sweetnam, Kevin C. Eggan, Denny Sakkas

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2018)

Article Obstetrics & Gynecology

To test or not to test? A framework for counselling patients on preimplantation genetic testing for aneuploidy (PGT-A)

Lauren A. Murphy, Emily A. Seidler, Denis A. Vaughan, Nina Resetkova, Alan S. Penzias, Thomas L. Toth, Kim L. Thornton, Denny Sakkas

HUMAN REPRODUCTION (2019)

No Data Available